Skip to main content
. 2017 Mar 6;7:43393. doi: 10.1038/srep43393

Figure 2. Selection of candidate miRNAs in the discovery phase.

Figure 2

(A) Recurrence-free survival (RFS) analysis for 4 candidate miRNAs in the TCGA cohort of Stage II/III CRCs. (B) The expression levels of the candidate miRNAs measured by qRT-PCR in stage III CRC tissues which included 12 recurrence-positive and 12 non-negative CRC patients.